Xylem Inc. XY6.DE XETRA · Industrials · United States
97.87 € +1.50% +1.45 €
Summary
72 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 26% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- It has raised its dividend 5 years in a row and pays out only 35% of profit.
What to watch
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 23.3 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 18% a year. For the next fiscal year analysts expect revenue to grow by 1.3%. Earnings per share grew by 26% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 60 USD
- Research and development 2.5 USD
- Sales and administration 21 USD
- Taxes and other 4.0 USD
- Net profit 12 USD
Net profit, industry median (Industrial - Machinery) 7.0 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.48%
- Paid out of profit
- 35%
- Raised in a row
- 5 years
You receive 1.45 € per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 18
- Hold 22
- Sell 2
No analyst has published a price target.
43% of the analysts recommend buying.
Analysts in detail